[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 20, 1924


Author Affiliations

Secretary, Council on Pharmacy and Chemistry of the American Medical Association CHICAGO

JAMA. 1924;83(25):2018. doi:10.1001/jama.1924.26610250004014b

Mammary gland preparations were admitted to New and Nonofficial Remedies when there was promise that they might be found to have therapeutic value. In 1921, the Council considered the question of continuing these products in New and Nonofficial Remedies. In view of the slight evidence for the therapeutic value that had accumulated during the many years of their trial, the Council decided to omit these preparations from the book.1

To determine whether the status of these products had changed, letters were written to a number of men who might be expected to be conversant with the present status of therapy with mammary gland preparations. Great difficulty was encountered in finding any medical men of standing who would undertake to write on the subject. The appeal was made to a leading gynecologist, a leading obstetrician, a leading pharmacologist and a man closely identified with the field of internal secretions. Answers